Institutional investors purchased a net $5.6 million shares of PDLI during the quarter ended December 2015 and now own 83.00% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APERIO GROUP LLC Bought 266.2 Thousand shares of PDL BioPharma Inc
RUSSELL INVESTMENT MANAGEMENT CO... Bought 179.0 Thousand shares of PDL BioPharma Inc
STATE TEACHERS RETIREMENT SYSTEM... Bought 61.5 Thousand shares of PDL BioPharma Inc